Back to Journals » Clinical Ophthalmology » Volume 3

Two-step LASIK after penetrating keratoplasty

Authors Kollias A, Schaumberger MM, Kreutzer TC, Ulbig MW, Lackerbauer CA

Published 20 October 2009 Volume 2009:3 Pages 581—586

DOI https://doi.org/10.2147/OPTH.S7332

Review by Single-blind

Peer reviewer comments 3


Aris N Kollias, Markus M Schaumberger, Thomas C Kreutzer, Michael W Ulbig, Carlo A Lackerbauer

University Eye Hospital, Ludwig-Maximilians University, Munich, Germany

Purpose: The point of interest of this retrospective case review is to study refractive changes caused by the hinged lamellar keratotomy and the refractive outcome after laser ablation in a second step within the scope of laser in situ keratomileusis (LASIK) in patients with penetrating keratoplasty.

Methods: Data from eight patients obtained before lamellar keratotomy, before laser ablation, and three months later were evaluated. Keratotomies were performed with the Moria® LSK one and the Amadeus® 2 microkeratome, laser ablation was performed with the Schwind® Keratome I and the Wavelight® Allegretto WaveEyeQ.

Results: Uncorrected visual acuity (UCVA) improved significantly from 1 [logMar] to 0.4 [logMar] at the last visit. Median gain of UCVA was 7.38 ± 2.96 Snellen lines. Best spectacle-corrected visual acuity did not change significantly. Preoperative manifest refraction spherical equivalent decreased from -4.02 ± 4.77 diopters (D) to -1.11 ± 2.45 D after laser ablation. Mean preoperative manifest astigmatism was -7.27 ± 3.65 D, after lamellar keratotomy -6.72 ± 3.68 D, and after laser ablation -2.08 ± 1.80 D. Manifest astigmatism did not change significantly after the keratotomy.

Conclusions: Lamellar keratotomy causes biomechanical changes to the cornea. We favor a two-step LASIK in penetrating keratoplasty patients in order to improve precision and predictability of the refractive outcome.

Keywords: two-step, cornea, LASIK, keratoplasty, astigmatism

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]